EN
HI

Concord Drugs Share price

CONCORD

49.47

8.24 (19.99%)
Last updated on 1 Jul, 2025 | 15:25 IST
BUYSELL
Today's High

49.47

Today's Low

42.30

52 Week Low

26.10

52 Week High

49.47

The current prices are delayed, login to your account for live prices

Concord Drugs Chart

Concord Drugs Share Key Metrics

Volume
2.58 L
Market Cap
41.23 CR
LTQ@LTP
100@49.47
ATP
47.18
Var Margin
26.64 %
Circuit Range
32.99-49.47
Delivery %
0 %
Value
1.22 CR
ASM/GSM
No
Market Lot
1

Concord Drugs Futures & Options

Data Not Found

Concord Drugs Corporate Actions

DateAgenda
2025-06-27Preferential Issue of shares & Others
2025-05-23Audited Results
2025-03-17Preferential Issue of shares & Others
2025-03-13Preferential Issue of shares & Others
2025-01-11Quarterly Results
DateEvent TypeAgenda
2025-06-27Board MeetingPreferential Issue of shares & Others
2025-05-23Board MeetingAudited Results
2025-03-17Board MeetingPreferential Issue of shares & Others
2025-03-13Board MeetingPreferential Issue of shares & Others
2025-01-11Board MeetingQuarterly Results

Concord Drugs News

BRIEF-Concord Drugs Says Approved Sale Of Non-Agricultural/Industrial Land, Ground, With Structures In Uttarakhand State

Oct 13 2020 19:21:03
Read More

About Concord Drugs

NSE : 0  
BSE : 538965  
ISIN : INE858L01010  

CONCORD DRUGS LIMITED a company with its registered office at 5-9-22/36 Adarsha Nagar Hyderabad - 500463 (With effect from 14196 as for resolution dated 1.4.96 Change of Registered Office is being file with ROC was incorporated as a public limited company on 24th April 1995. The factory of the company is situated at survey No.s 248-251 Torruru Village Brahmanapally post Hyathnagar mandal R.R.Dist. Andhra Pradesh. The main objects of the company is to carry on the business of manufacturing and selling of pharmaceuticals formulations i.e. Tablets Capsules Liquids and Sterile Powder Injections Bio Adhesive and Radio Opec agent.SUBSIDIARIES OF THE COMPANYThe company has no subsidiary.

Concord Drugs Management

NamePosition
Mr. S Nagi Reddy Chairman & Managing Director
Mr. S Manoj Kumar Reddy Whole Time Director
Mr. S Koni Reddy WholeTime Director & CFO
Mr. K Ramachandra Reddy Independent Director
Ms. Sumeela Kasu Independent Director
Read More

Concord Drugs FAQs

The Buying Price of Concord Drugs share is 49.47 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Concord Drugs share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of Concord Drugs shares is 122.71. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Concord Drugs shares is 1.21. Useful to assess the stock's value relative to its book value.

To assess Concord Drugs’s valuation compare Sector P/E, P/B which are 29.91 & 4.03 with sector averages, along with growth rates and financial metrics.

The Market Cap of Concord Drugs is 41.23 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Concord Drugs share price is 49.47 & 26.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.